Find the latest news on Coya Therapeutics
News
| The ALS Association, Muscular Dystrophy Association, and ALS Finding a Cure Provide Additional Funding for Novel ALS Research |
|
| Coya Raises $10M to Advance T-cell Therapy Now in Phase 2 ALS Trial |
|
| Senior AbbVie liaison quits job to launch neuro startup, with sights set on ALS |
|
Press Releases
|
Jul 14, 2021
Coya Therapeutics to Participate at the LifeSci Partners Summer Symposium
|
|
|
Jul 07, 2021
Coya Therapeutics Receives Orphan Drug Designation from the FDA for ALS001, an Autologous Treg Cell Therapy, for the Treatment of ALS
|
|
|
Jun 02, 2021
Coya Therapeutics to Host Key Opinion Leader Webinar on ALS001 for the Treatment of Amyotrophic Lateral Sclerosis
|
|
Blog
|
Jun 28, 2021
The Forest Fire Behind Neurodegenerative Diseases
|
|
|
Jun 07, 2021
My Personal Journey to a Cure for ALS
|
|
|
Apr 28, 2021
A Serendipitous Moment
|
|
Events
|
Jun 11, 2021
Houston, TX., June 11, 2021 -- Coya Therapeutics, Inc., (Coya™), a clinical-stage biotechnology... |
